Skip to main content
SpringerLink
Log in

CHMP endorses PRAC advice, restricts use of RAS-acting agents

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. see Reactions 1499 p3; 803102510

Reference

  • EMA. Combined use of medicines affecting the renin-angiotensin system (RAS) to be restricted - CHMP endorses PRAC recommendation. Internet Document : [4 pages], 23 May 2014. Available from: URL: http://www.ema.europa.eu

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

CHMP endorses PRAC advice, restricts use of RAS-acting agents. Reactions Weekly 1504, 2 (2014). https://doi.org/10.1007/s40278-014-1197-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-014-1197-7

Search

Navigation